e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Exhaled biomarkers in children and adults with airways disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC
Olaf Holz (Hannover, Germany), Arne Gaida, Olaf Holz, Shirin Nahidi, Sven Schuchardt, Christoph Nell, Rembert Koczulla, Jens Hohlfeld
Source:
International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Session:
Exhaled biomarkers in children and adults with airways disease
Session type:
Poster Discussion
Number:
2086
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Olaf Holz (Hannover, Germany), Arne Gaida, Olaf Holz, Shirin Nahidi, Sven Schuchardt, Christoph Nell, Rembert Koczulla, Jens Hohlfeld. Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC. Eur Respir J 2015; 46: Suppl. 59, 2086
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: respiratory care for newborns in resource-limited settings
Respiratory sequelae of preterm birth across the life span
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Breathprint of severe allergic asthma with SPME-GC-MS Analysis of exhaled air volatile organic compounds(Ege University translational pulmonology research group [EgeTPAG])
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function
Source: International Congress 2015 – The next generation of lung function tests
Year: 2015
Measuring exhaled hydrogen sulphide (eH2S) levels in asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Can exhaled volatile organic compounds predict asthma exacerbations in children?
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Do volatile organic compounds (VOCs) discriminate between eosinophilic and neutrophilic asthma phenotype?
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Hydrogen sulfide (H
2
S) in sputum and serum as a novel biomarker of COPD
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Volatile organic compounds (VOC) in exhaled breath of patients with COPD
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Volatile organic compounds (VOCs) in COPD patients with exacerbation
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Airborne concentration of limonene (a volatile organic compound (VOC)), when using a spray of 41 essential oils
Source: Annual Congress 2013 –Outdoor and indoor environment: respiratory diseases from asthma to asbestosis
Year: 2013
Hydrogen sulphide as a biomarker in COPD and asthma
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort
Source: Eur Respir J, 57 (2) 2002127; 10.1183/13993003.02127-2020
Year: 2021
Measurement of volatile organic compounds in exhaled breath of children of the ALL Age Asthma Cohort
Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities
Year: 2018
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD
Source: Eur Respir J 2011; 38: 1301-1309
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept